Jump to Navigation
Jump to Content

Daubert v. Merrell Dow Pharmaceuticals, Inc.

Citation: 25 ELR 20856
No. No. 90-5537, 43 F.3d 1311/(9th Cir., 01/04/1995) On remand

On remand from the U.S. Supreme Court, the court holds inadmissible under Fed. R. Evid. 702 expert testimony offered to prove that plaintiffs' mothers' ingestion of the drug Bendectin during pregnancy caused the plaintiffs to be born with limb-reduction birth defects....

You must be an ELR subscriber to view the full case summary.

You are not logged in. To access this content: